|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Realized gain on sale of real estate investments | |||||
| Unrealized loss (gain) on changes in fair value of real estate-related securities | |||||
| Realized (gain) loss on sale of real estate-related securities | |||||
| Unrealized (gain) loss on changes in fair value of real estate debt | |||||
| Unrealized (gain) loss on changes in fair value of note payable | |||||
| Unrealized loss (gain) on changes in fair value of commercial mortgage loans | |||||
| Commercial Mortgage Loans | |||||
| Total unrealized loss (gain) on changes in fair value of commercial mortgage loans | |||||
| Unrealized (gain) loss on changes in fair value of interest rate derivatives | |||||
| Realized (gain) loss on sale of real estate debt | |||||
| (Loss) income from equity investments in unconsolidated international affiliated funds | |||||
| Income distributions from equity investments in unconsolidated international affiliated funds | |||||
| Payment-in-kind interest on commercial mortgage loans | |||||
| Straight-line rent adjustment | |||||
| Amortization of above- and below-market lease intangibles | |||||
| Amortization of deferred financing costs | |||||
| Amortization of mortgage discount | |||||
| Amortization of restricted stock grants | |||||
| Change in assets and liabilities: | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in accounts payable, accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions of real estate | |||||
| Origination and fundings of commercial mortgage loans | |||||
| Proceeds from paydown of commercial mortgage loans | |||||
| Funding for investment in international affiliated funds | |||||
| Capital improvements to real estate | |||||
| Proceeds from sale of real estate investments | |||||
| Purchase of real estate-related securities | |||||
| Proceeds from sale of real estate-related securities | |||||
| Purchases of real estate debt | |||||
| Proceeds from sale of real estate debt | |||||
| Deposits on real estate property | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Repurchase of common stock | |||||
| Offering costs paid | |||||
| Borrowings under credit facility | |||||
| Repayments on credit facility | |||||
| Borrowings from mortgages payable | |||||
| Payments on mortgages payable | |||||
| Borrowings under note payable | |||||
| Payment of deferred financing costs | |||||
| Proceeds from sale of loan participations | |||||
| Contributions from non-controlling interests | |||||
| Payment of offering and organization costs due to affiliate | |||||
| Distributions to preferred stockholders | |||||
| Repurchase of preferred stock | |||||
| Distributions to non-controlling interests | |||||
| Subscriptions received in advance | |||||
| Distributions | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash during the period | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures: | |||||
| Interest paid | |||||
| Right-of-use asset obtained in exchange for new operating lease liability (non-cash transaction) | |||||
| Non-cash investing activities: | |||||
| Assumption of other assets and liabilities in conjunction with acquisitions of investments in real estate | |||||
| Accrued capital expenditures | |||||
| Payment-in-kind interest on commercial mortgage loans | |||||
| Fundings of commercial mortgage loans through increases in loan participations | |||||
| Paydown of commercial mortgage loans through decrease in loan participations | |||||
| Proceeds receivable from sale of real estate debt | |||||
| Proceeds receivable from sale of real estate-related securities | |||||
| Accrued purchases of real estate debt | |||||
| Accrued purchases of real estate-related securities | |||||
| Non-cash financing activities: | |||||
| Right-of-use assets obtained in exchange for new finance lease liabilities | |||||
| Assumption of mortgages payable in conjunction with acquisitions of investments in real estate | |||||
| Accrued offering costs | |||||
| Accrued distributions | |||||
| Accrued stockholder servicing fees | |||||
| Distribution reinvestments | |||||
| Allocation to redeemable non-controlling interests | |||||
| Increases in loan participations through fundings of commercial mortgage loans | |||||
| Decrease in loan participations through paydown of commercial mortgage loans | |||||
| Reconciliation of cash and cash equivalents and restricted cash to the Consolidated Balance Sheets, end of period: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...
